Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tiratricol in children with MCT8 deficiency
NCT02396459Phase 2Active, not recruiting
- Sponsor
- Egetis Therapeutics
- Start
- Dec 2020
- Primary completion
- Jul 2027
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 2 trial of tiratricol in Allan-Herndon-Dudley syndrome (AHDS), sponsored by Egetis Therapeutics. Started Dec 2020; status: active, not recruiting.
02
Drugs
tiratricol
03
Conditions
Allan-Herndon-Dudley syndrome (AHDS)
Beyond the preview
Go deeper on NCT02396459.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02396459.